Evidence map›Paper›PMID 40291164›Full record

ArticleCurrent treatment options in cardiovascular medicine2024

Next-Generation Cardiac Magnetic Resonance Imaging Techniques for Characterization of Myocardial Disease.

Julia Simkowski, Brendan Eck, W H Wilson Tang, Christopher Nguyen, Deborah H Kwon

Abstract read
In one paragraph

Article in Current treatment options in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julia SimkowskiHeart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Brendan EckDiagnostic Services, Cleveland Clinic, Cleveland, OH, USA.
W H Wilson TangHeart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Christopher NguyenHeart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Deborah H KwonHeart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Funding

Serial evaluation of cardioprotective effects of exercise training in heart failure using cardiac diffusion tensor MRIR01HL151704 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NGUYEN, CHRISTOPHER T · 2020 to 2024
$3.4M
Microstructural Response of the Myocardium to Mechanical LoadR01HL159010 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MEKKAOUI, CHOUKRI, NGUYEN, CHRISTOPHER T · 2021 to 2024
$3.2M
Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral RegurgitationR01HL170090 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI DEBORAH KWON · 2023 to 2026
$3.1M
Modeling, measurement and prediction of cardiac magneto-stimulation thresholdsR01EB033853 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Bastien Guerin, Christopher T Nguyen · 2023 to 2026
$2.4M
Characterization of sarcopenia in heart failure by T1rho magnetic resonance fingerprintingK25AG070321 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI ECK, BRENDAN LEE · 2022 to 2024
$412k
NHLBI NIH HHS R01 HL151704NHLBI NIH HHS R01 HL159010NHLBI NIH HHS R01 HL170090NIA NIH HHS K25 AG070321NIBIB NIH HHS R01 EB033853
6 · The paper itself

Abstract

Purpose of the Review: Many novel cardiac magnetic resonance imaging (cMR) techniques have been developed for diagnosis, risk stratification, and monitoring of myocardial disease. The field is changing rapidly with advances in imaging technology. The purpose of this review is to give an update on next-generation cMR techniques with promising developments for clinical translation in the last two years, and to outline clinical applications. Recent Findings: There has been increasing widespread clinical adoption of T1/T2 mapping into standard of care clinical practice. Development of auto segmentation has enabled clinical integration, with potential applications to minimize the use of contrast. Advances in diffusion tensor imaging, multiparametric mapping with cardiac MRI fingerprinting, automated quantitative perfusion mapping, metabolic imaging, elastography, and 4D flow are advancing the ability of cMR to provide further quantitative characterization to enable deep myocardial disease phenotyping. Together these advanced imaging features further augment the ability of cMR to contribute to novel disease characterization and may provide an important platform for personalized medicine. Summary: Next-generation cMR techniques provide unique quantitative imaging features that can enable the identification of imaging biomarkers that may further refine disease classification and risk prediction. However, widespread clinical application continues to be limited by ground truth validation, reproducibility of the techniques across vendor platforms, increased scan time, and lack of widespread availability of advanced cardiac MRI physicists and expert readers. However, these techniques show great promise in minimizing the need for invasive testing, may elucidate novel pathophysiology, and may provide the ability for more accurate diagnosis of myocardial disease.

Indexed as

Artificial IntelligenceCardiac MRIDiffusion Tensor ImagingMagnetic Resonance FingerprintingQuantitative Parametric Mapping

Identifiers

PMID40291164
PMCPMC12030006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.